Preliminary safety results of the open-label phase of a 2-part phase 1b study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of an investigational microbiome therapeutic, SER-155, in adults undergoing hematopoietic cell transplantation Meeting Abstract

  

Authors:	Ponce, D. M.; Kosuri, S.; Khera, N.; Defilipp, Z.; Lichter, D. I.; Peled, J. U.; van den Brink, M. R. M.; Brady, K.; Puhl, M. D.; Glick, G.; Hasson, B.; McGovern, B. H.; von Moltke, L.; Tejura, B.
Abstract Title:	Preliminary safety results of the open-label phase of a 2-part phase 1b study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of an investigational microbiome therapeutic, SER-155, in adults undergoing hematopoietic cell transplantation
Meeting Title:	65th Annual Meeting of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	142
Issue:	Suppl. 1
Meeting Dates:	2023 Dec 9-12
Meeting Location:	San Deigo, CA
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2023-11-02
Start Page:	6994
Language:	English
ACCESSION:	WOS:001159900807068
DOI:	10.1182/blood-2023-180119
PROVIDER:	wos
Notes:	Meeting Abstract -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/215391